Invasive revascularization strategy in non-ST-segment acute coronary syndromes. The debate continues;Estrategia de revascularización invasiva en el síndrome coronario sin elevación del segmento ST. El debate continúa

Medicina Clinica

Volumn 133, Issue 18, 2009, Pages 717-723

  Núñez, Julio ^a   Sanchis, Juan ^a   Bodí, Vicent ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Invasive Strategy; Non ST Segment Acute Coronary Syndromes; Prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PROGNOSIS; REVASCULARIZATION; SHORT SURVEY; ST SEGMENT;

ACUTE CORONARY SYNDROME; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; MYOCARDIAL REVASCULARIZATION;

EID: 70350568227     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.12.017     Document Type: Short Survey

References (41)

1. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology ot the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
2. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernández-Avilés F., et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28 (2007) 1598-1660
3. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 89 (1994) 1545-1556
4. McCullough P.A., O'Neill W.W., Graham M., Stomel R.J., Rogers F., David S., et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. J Am Coll Cardiol 32 (1998) 596-605
5. Boden W.E., O'Rourke R.A., Crawford M.H., Blaustein A.S., Deedwania P.C., Zoble R.G., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Eng J Med 338 (1998) 1785-1792
6. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
7. Kaul P., Fu Y., Chang W.Ch., Harrington R.A., Wagner G.S., Goodman S.G., et al. Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. J Am Coll Cardiol 38 (2001) 64-71
8. Bodí V., Facila L., Sanchis J., Llácer A., Núñez J., Mainar L., et al. Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda. Rev Esp Cardiol 55 (2002) 823-830
9. Bodí V., Sanchis J., Llàcer A., Fácila L., Núñez J., Pellicer M., et al. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J 149 (2005) 268-274
10. Sanchís J., Bodí V., Llácer A., Facila L., Martínez-Brotons A., Insa L., et al. Relación de los valores de proteína C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol 57 (2004) 382-387
11. Sanchis J., Bodí V., Llácer A., Facila L., Núñez J., Bertomeu V., et al. Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes. Am J Cardiol 91 (2003) 448-451
12. Bavry A.A., Kumbhani D.J., Quiroz R., Ramchandani S.R., Kenchaiah S., and Antman E.M. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 93 (2004) 830-835
13. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., and Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 356 (2000) 9-16
14. Lagerqvist B., Husted S., Kontny F., Ståhle E., Swahn E., Wallentin L., et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368 (2006) 998-1004
15. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Eng J Med 344 (2001) 1879-1887
16. Fox K.A., Poole-Wilson P.A., Henderson R.A., Clayton T.C., Chamberlain D.A., Shaw T.R., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 360 (2002) 743-751
17. Fox K.A., Poole-Wilson P., Clayton T.C., Henderson R.A., Shaw T.R., Wheatley D.J., et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 366 (2005) 914-920
18. López Bescos L., Arós F., Lidón R.M., Cequier A., Bueno H., Alonso J.J., et al. Actualización (2002) de las guías de práctica clínica de la Sociedad Española de Cardiología en angina inestable/infarto sin elevación del segmento ST. Rev Esp Cardiol 55 (2002) 631-642
19. De Winter R.J., Windhausen F., Cornel J.H., Dunselman P.H., Janus C.L., Bendermacher P.E., et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
20. Thygesen K., Alpert J.S., White H.D., and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
21. Hirsch A., Windhausen F., Tijssen J.G., Verheugt F.W., Cornel J.H., De Winter R.J., et al. Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet 369 (2007) 827-835
22. Choudhry N.K., Singh J.M., Barolet A., Tomlinson G.A., and Detsky A.S. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials. Am J Med 118 (2005) 465-474
23. Mehta S.R., Cannon C.P., Fox K.A., Wallentin L., Boden W.E., Spacek R., et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 293 (2005) 2908-2917
24. Qayyum R., Khalid M.R., Adomaityte J., Papadakos S.P., and Messineo F.C. Systematic review: comparing routine and selective invasive strategies for the acute coronary syndrome. Ann Intern Med 148 (2008) 186-196
25. Bhatt D.L., Roe M.T., Peterson E.D., Li Y., Chen A.Y., Harrington R.A., et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 292 (2004) 2096-2104
26. Bodí V., Sanchis J., Llácer A., Fàcila L., Núñez J., Pellicer M., et al. Estrategia invasiva en el síndrome coronario agudo sin elevación del segmento ST. De los grandes estudios al mundo real. Rev Esp Cardiol 57 (2004) 1143-1150
27. Núñez J., Sanchis J., Núñez E., Bodi V., Bertomeu-González V., Bosch M.J., et al. Prognostic differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: experience from two consecutive periods in a single center. Eur J Intern Med 18 (2007) 409-416
28. Bauer T., Koeth O., Jünger C., Heer T., Wienbergen H., Gitt A., et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J 28 (2007) 2873-2878
29. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290 (2003) 1624-1632
30. Fox K.A., Goodman S.G., Klein W., Brieger D., Steg P.G., Dabbous O., et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 23 (2002) 1177-1189
31. Núñez J.E., Núñez E., Fácila L., Bertomeu V., Llàcer A., Bodí V., et al. Papel del índice de Charlson en el pronóstico a 30 días y 1 año tras un infarto agudo de miocardio. Rev Esp Cardiol 5 (2004) 842-849
32. Steg P.G., Dabbous O.H., Feldman L.J., Cohen-Solal A., Aumont M.C., López-Sendón J., et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004) 494-499
33. Bach R.G., Cannon C.P., Weintraub W.S., DiBattiste P.M., Demopoulos L.A., Anderson H.V., et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 141 (2004) 186-195
34. Januzzi J.L., Cannon C.P., DiBattiste P.M., Murphy S., Weintraub W., Braunwald E., et al. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol 90 (2002) 1246-1249
35. Freemantle N., Calvert M., Wood J., Eastaugh J., and Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty?. JAMA 289 (2003) 2554-2559
36. Kip K.E., Hollabaugh K., Marroquin O.C., and Williams D.O. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol 51 (2008) 701-707
37. Ferreira-González I., Busse J.W., Heels-Ansdell D., Montori V.M., Akl E.A., Bryant D.M., et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 334 (2007) 786
38. Akkerhuis K.M., Alexander J.H., Tardiff B.E., Boersma E., Harrington R.A., Lincoff A.M., et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention related events different?. Circulation 105 (2002) 554-556
39. Jeremias A., Baim D.S., Ho K.K., Chauhan M., Carrozza Jr. J.P., Cohen D.J., et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 44 (2004) 1210-1214
40. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., and Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 104 (2001) 642-647
41. Stone G.W. Non-ST-elevation acute coronary syndromes. Lancet 369 (2007) 827-835